¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sclerosing agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® cardiotonic, cardiotonic agent ÇÑ±Û °­½ÉÁ¦
¼³¸í   
  ½ÉÀåÀÇ ¼öÃà·ÂÀ» Áõ°¨½Ã۴ ¾à¹°À» ¸»ÇÑ´Ù. ±âº»ÀûÀ¸·Î ½É±Ù¼öÃà·ÂÀ» Áõ°­½ÃÄÑ ½ÉÀå¹ÚÃâ·®À» Áõ°¡½Ã۴ ¾à¹°ÀÌ´Ù. °­½É¹è´çü, Æ÷½ºÆ÷µð¿¡½ºÆ®¶ó¾ÆÁ¦ ¾ïÁ¦Á¦, ¾Æµå·¹³¯¸° ¥â¼ö¿ëüÀÛ¿ëÁ¦, Ç÷°üÈ®ÀåÁ¦ µîÀÌ ÀÖ´Ù. ´ëÇ¥ÀûÀΠ¿¹·Î¼­´Â µð°î½Å(digoxine) µîÀÇ µðÁöÅ»¸®½º(digitalis)°¡ ÀÖ´Ù.
¿µ¹® alkylating agent ÇÑ±Û ¾Ëųȭ¾à¹°
¼³¸í   
  Ç×¾ÏÁ¦ÀÇ ÀÏÁ¾. ÀÌ»óÀûÀΠÇ×¾ÏÁ¦´Â Á¤»óÀûÀΠ¼¼Æ÷¿¡´Â Çظ¦ ÁÖÁö ¾Ê°í ´ÜÁö ¾Ï¼¼Æ÷¿¡¸¸ Ä¡¸íÀûÀΠȿ°ú¸¦ ³ªÅ¸³»¾ß ÇÑ´Ù. ÀÌ·¸°Ô ÇÏ·Á¸é ¾Ï¼¼Æ÷¸¸ÀǠƯÀÌÇѠƯ¼ºÀ» ÀÌÇØÇÏ°í ±×°÷¿¡¸¸ ÀÛ¿ëÇϴ ¾à¹°À» °³¹ßÇØ¾ß ÇÑ´Ù. ÇöÀç ´ëºÎºÐÀÇ Ç×¾ÏÁ¦´Â ¾Ï¼¼Æ÷°¡ Á¤»ó ¼¼Æ÷¿¡ ºñÇÏ¿© ¿ùµîÈ÷ Áõ½ÄÀ» »¡¸®ÇѴٴ Ư¼ºÀ» ÀÌ¿ëÇϰí ÀÖ´Ù. Áõ½ÄÀÌ ºü¸£´Ù´Â °ÍÀº ´Ù½Ã ¸»Çϸé À¯Àü Á¤º¸¸¦ °¡Áö°í Àִ DNAÀÇ º¹Á¦°¡ ºü¸£´Ù´Â °ÍÀ» ÀǹÌÇÑ´Ù. ¸¸¾à DNAÀÇ º¹Á¦¸¦ ¹æÇØÇÑ´Ù¸é Áõ½ÄÀÌ ¾ÆÁÖ ºü¸¥ ¾Ï¼¼Æ÷¿¡°Ô´Â Ä¡¸íÀûÀÌÁö¸¸ ¿µ¿øÈ÷ Áõ½ÄÀ» ÇÏÁö ¾Ê´Â DNAÀÇ º¹Á¦°¡ °ÅÀÇ ÇÊ¿ä¾ø´Â)½Å°æ¼¼Æ÷³ª Áõ½ÄÀÌ ¾Ï¼¼Æ÷¿¡ ºñÇØ¼­ ¾ÆÁÖ ´À¸° Á¤»ó¼¼Æ÷¿¡´Â °ÅÀÇ ¿µÇâÀ» ÁÖÁö ¸øÇÑ´Ù. ÇÏÁö¸¸ ½Åü¿¡¼­µµ Áõ½ÄÀÌ ¾Ï¼¼Æ÷¿Í ºñ½ÁÇÑ ¼öÁØÀ¸·Î ÀϾ´Â Á¤»óÀûÀΠ¼¼Æ÷°¡ Àִµ¥ ±×°ÍÀº ¸Ó¸®Ä«¶ôÀ» ¸¸µå´Â ¸ð³¶¼¼Æ÷¿Í ¼ÒÈ­°üÀÇ Á¡¸·À» ÀÌ·ç´Â ¼¼Æ÷¿Í Ç÷¾×ÀÇ ¼¼Æ÷¸¦ ¸¸µå´Â °ñ¼ö ¼¼Æ÷ÀÌ´Ù. ±×·¯¹Ç·Î Ç×¾ÏÁ¦¸¦ »ç¿ëÇÒ °æ¿ì ¾Ï¼¼Æ÷¿Í ¸¶Âù°¡Áö·Î À̵頼¼Æ÷µµ ÇÔ²² Ä¡¸íÀûÀΠ¿µÇâÀ» ÀÔÀ» °ÍÀº ´ç¿¬ÇÏ´Ù(±×·¡¼­ Ç×¾ÏÁ¦ Ä¡·á½Ã¿£ ¸Ó¸®°¡ ºüÁö°í ¼ÒÈ­ºÒ·®ÀÌ Àß ¿Â´Ù). ¾ËĮȭ¾à¹°ÀÇ °æ¿ì¿¡´Â DNA¿Í Á÷Á¢ °áÇÕÀ» ÇÏ¿© DNAÀÇ º¹Á¦¸¦ ¾ïÁ¦ÇÔÀ¸·Î½á Ç×¾ÏÁ¦ÀÇ ¿ªÇÒÀ» ¼öÇàÇÑ´Ù.
¿µ¹® anti-inflammatory agent ÇÑ±Û Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
¼³¸í   
  ±¹¼Ò¿¡ ÀÛ¿ëÇÏ¿© ¿°ÁõÀ» Ä¡·áÇÏ°í ¹æÁöÇϴ ¾à. ¿°ÁõÀ» °¡¶ó¾ÉÈ÷´Â ¾àÀ» ¸»ÇÑ´Ù. Á¶Á÷À» ±äÃà-Ä¡¹ÐÇϰԠÇÏ¿© Àå¾×°ú Á¡¾×ÀÇ ºÐºñ¸¦ ÁÙÀ̰í, Ç¥¸é¿¡ Àִ ÀÛÀº Ç÷°ü¿¡ ºóÇ÷À» ÀÏÀ¸ÄÑ ÃæÇ÷µÇ´Â °ÍÀ» ¹æÁöÇÔÀ¸·Î½á ¿°ÁõÀû º´º¯À» Á¦°ÅÇÏ¿© ¸ðµç Áõ¼¼¸¦ ¾ø¾Ø´Ù. ´ëºÎºÐÀÇ ¼ö·ÅÁ¦-¿ÏÈ­Á¦-Áø¾çÁ¦°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. Áß¿äÇÑ ¼ººÐÀ¸·Î´Â ¾Ë·ç¹Ì´½-ºñ½º¹«Æ®-¾Æ¿¬-³³È­ÇÕ¹°(º´¹Ý-Æä¸£¸¶Åç-¾Æ¿¬È­-¿¬´ç µî) µîÀÌ ÀÖ´Ù. ÀÛ¿ë¿¡ µû¶ó Ç׿°ÁõÁøÅëÁ¦¿Í Ç׿°ÁõÈ¿¼ÒÁ¦·Î ³ª´¶´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing agent
    °æÈ­Á¦
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subacute sclerosing panencephalitis
    ¾Æ±Þ¼º°æÈ­¹ü³ú¿°
  • sclerosing
    °æÈ­-
  • sclerosing adenosis
    °æÈ­»ùÁõ, °æÈ­¼±Áõ
  • sclerosing angioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°, °æÈ­´ã°ü¿°
  • sclerosing epithelial hamartoma
    °æÈ­Ç¥Çǰú¿ÀÁ¾
  • sclerosing fibrosis
    °æÈ­¼¶À¯Áõ
  • sclerosing gastritis
    °æÈ­À§¿°
  • sclerosing hemangioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing inflammation
    °æÈ­¿°Áõ
  • sclerosing keratitis
    °æÈ­°¢¸·¿°
  • sclerosing liposarcoma
    °æÈ­Áö¹æÀ°Á¾
  • sclerosing mastoiditis
    °æÈ­²ÀÁöµ¹±â¿°, °æÈ­À¯µ¹¿°
  • sclerosing osteogenic sarcoma
    °æÈ­»ÀÀ°Á¾, °æÈ­°ñÀ°Á¾
  • sclerosing retroperitonitis
    °æÈ­Èĺ¹¸·¿°, °æÈ­¹è¸·µÚ¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing agent
    °æÈ­Á¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°
  • sclerosing
    °æÈ­-
  • agent
    1. ¾à¹°, ¾àÁ¦, 2. ¹°Áú, 3. ÀÎÀÚ
  • alkylating agent
    ¾Ëųȭ¾à¹°, ¾ËųȭÁ¦
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • antiasthmatic agent
    Ç×õ½ÄÁ¦
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antimetabolic agent
    Ç×´ë»ç¹°Áú
  • antitumor agent
    Ç×¾ÏÁ¦
  • blocking agent
    Â÷´ÜÁ¦
  • etiologic agent
    ¿øÀÎü, º´ÀÎü
  • hyperosmotic agent
    °í»ïÅõ¾ÐÁ¦
  • induction agent
    À¯µµ¹°Áú
  • infectious agent
    °¨¿°Ã¼, °¨¿°¿ø
  • oxidizing agent
    »êÈ­Á¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing agent
    °æÈ­Á¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing adenitis
    °æÈ­»ù¿°
  • sclerosing adenosis
    °æÈ­»ùÁõ
  • sclerosing angioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°
  • subacute sclerosing encephalitis
    ¾Æ±Þ¼º°æÈ­³ú¿°
  • sclerosing fibrosis
    °æÈ­¼¶À¯Áõ
  • sclerosing gastritis
    °æÈ­À§¿°
  • sclerosing hemangioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing histoplasmosis
    °æÈ­È÷½ºÅäÇö󽺸¶Áõ
  • sclerosing epithelial hamartoma
    °æÈ­Ç¥Çǰú¿ÀÁ¾
  • sclerosing inflammation
    °æÈ­¿°Áõ
  • sclerosing keratitis
    °æÈ­°¢¸·¿°
  • radial sclerosing lesion
    ¹æ»ç»ó°æÈ­º´ÅÍ
  • sclerosing lipogranuloma
    °æÈ­Áö¹æÀ°¾ÆÁ¾
  • sclerosing liposarcoma
    °æÈ­Áö¹æÀ°Á¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenosis, sclerosing
    °æÈ­¼º ¼±Á¾(ÌãûùàõàÍðþ)
  • garres sclerosing osteomyelitis
    °æÈ­¼º °ñ¼ö¿°
  • hereditary sclerosing poikiloderma
    À¯Àü¼º °æÈ­¼º ´ÙÇüÇǺÎÁõ
  • histoplasmosis,sclerosing
    °æÈ­¼º
  • primary sclerosing cholangitis
    ¿ø¹ß(¼º) °æÈ­¼º ´ã°ü¿°(¡­ÌãûùàõÓÅηæú).
  • primary sclerosing cholangitis
    ¿ø¹ß(¼º) °æÈ­¼º ´ã°ü¿°(ê«Û¡(àõ) Ìãûùàõ ÓÅηæú)
  • radial sclerosing lesion
    ¹æ»ç¼º °æÈ­¼º º´º¯
  • Eaton agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ° º´¿øÃ¼
  • Eatons agent pneumonia
    ÀÌÆ°º´¿øÃ¼Æó·Å.
  • Norwalk agent
    ³ë¿öÅ© º´¿øÃ¼
  • Norwalk-like agent
    ³ë¸£¿ÍÅ©¾ç ü
  • Parvovirus-like agent
    ÆÄº¸¹ÙÀÌ·¯½º¾ç º´¿øÃ¼
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing agent
    °æÈ­¾à(Ìãûùå·).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenosis, sclerosing
    °æÈ­¼º ¼±Á¾(ÌãûùàõàÍðþ)
  • breast,sclerosing adenosis
    °æÈ­¼º ¼±Áõ (ÌãûùàõàÍñø)
  • garres sclerosing osteomyelitis
    °æÈ­¼º °ñ¼ö¿°
  • hemangioma,sclerosing
    °æÈ­¼º(Ìãûùàõ)
  • hereditary sclerosing poikiloderma
    À¯Àü¼º °æÈ­¼º ´ÙÇüÇǺÎÁõ
  • histoplasmosis,sclerosing
    °æÈ­¼º
  • osteomyelitis,garres sclerosing
    °¡·¹°æÈ­¼º(¡­Ìãûùàõ)
  • panencephalitis,subacute sclerosing
    ¾Æ±Þ¼º °æÈ­¼º(ä¬Ðáàõ Ìãûùàõ)
  • primary sclerosing cholangitis
    ¿ø¹ß(¼º) °æÈ­¼º ´ã°ü¿°(¡­ÌãûùàõÓÅηæú).
  • primary sclerosing cholangitis
    ¿ø¹ß(¼º) °æÈ­¼º ´ã°ü¿°(ê«Û¡(àõ) Ìãûùàõ ÓÅηæú)
  • radial sclerosing lesion
    ¹æ»ç¼º °æÈ­¼º º´º¯
  • retroperitonitis,sclerosing
    °æÈ­¼º(Ìãûùàõ)
  • sclerosing adenitis
    °æÈ­ ¼±¿°
  • sclerosing adenosis
    °æÈ­¼º¼±Áõ(¡­àõàÍñø)
  • sclerosing adenosis,of breast
    À¯¹æÀÇ(êáÛ®¡­)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antiprotozoal agent
    Ç׿øÃæÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Agent Orange
    ¿¡ÀÌÁ¨Æ® ¿À·»Áö
  • antibacterial agent
    Ç×±ÕÁ¦(ù÷жð¥)
  • antichaotropic agent
    Ç×(ù÷)ÄÉÀÌ¿À¼º(àõ) Á¦(ð¥)
  • antidotal agent
    ÇØµ¶Á¦Á¦(ú°Ô¸ð²ð¥)
  • antimitotic agent
    Ç×À¯»çºÐ¿­Á¦(ù÷êóÞêÝÂÖ®ð¥)
  • antithyroid agent
    Ç×°©»ó¼±Á¦(ù÷Ë£ßÒàÍð¥)
  • antiviral agent
    Ç×(ù÷) ¹ÙÀÌ·¯½ºÁ¦(ð¥)
  • bactericidal agent
    »ì±ÕÁ¦(߯жð¥)
  • bacteriostatic agent
    Á¤±ÕÁ¦(ð¡Ð¶ð¤)
  • chaotropic agent
    ¹«Áú¼­À¯¹ßÁ¦(Ùíòñßíë¯Û¡ð¥)
  • chelating agent
    ų·¹ÀÌÆ®Á¦(ð¥)
  • chemotherapeutic agent
    È­Çпä¹ýÁ¦(ûùùÊÖûÛöð¥)
  • cytostatic agent
    ¼¼Æ÷Áõ½Ä¾ïÁ¦Á¦(á¬øàñòãÖåäð¤ð¥)
  • denaturing agent
    º¯¼ºÁ¦(ܨàõð¥)
  • eluting agent
    ¿ë¸®Á¦(éÁ×îð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing agent
    °æÈ­¾à
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing
    °æÈ­(¼º)ÀÇ
  • sclerosing cholangitis
    °æÈ­¼º´ã°ü¿°
  • agent
    ¾à¹°, ÀÛ¿ë¹°Áú, º´ÀÎ
  • alkylating agent
    ¾ËųȭÁ¦, ¾Ëųȭ¾à¹°
  • anabolic agent
    µ¿È­¾à¹°
  • antitumor agent
    Ç׾Ͼà, Á¦¾Ï¾à
  • bleaching agent
    Ç¥¹éÁ¦
  • causative agent
    º´¿øÃ¼, ¿øÀι°Áú
  • chelating agent
    ŰÀÏ·¹ÀÌÆ®¾à
  • chemotherapeutic agent
    È­Çпä¹ýÁ¦
  • contrast agent
    Á¶¿µÁ¦
  • diagnostic agent
    Áø´Ü¿ë¾à
  • etiologic agent
    º´ÀÎü
  • gadolinium based contrast agent
    °¡µ¹¸®´½Á¶¿µÁ¦
  • immunosuppressive agent
    ¸é¿ª¾ïÁ¦¾à, ¸é¿ª¾ïÁ¦ÀÎÀÚ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SMCA smooth muscle contracting agent; suckling mouse cataract agent
PSC Primary Sclerosing Cholangitis
SSPE Subacute Sclerosing Pan-Encephalitis
ASHN acute sclerosing hyaline necrosis
FSGN focal sclerosing glomerulonephritis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NS Nodular Sclerosing
PSC Primary Sclerosing Cholangitis
SEP Sclerosing Encapsulating Peritonitis
SSPE Subacute Sclerosing Panencephalitis
NSHD nodular sclerosing Hodgkin disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sclerosing agent
    °æÈ­ ¾à, °æÈ­Á¦
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic diffuse sclerosing osteomyelitis
    ¸¸¼º ¹Ì¸¸¼º °æÈ­¼º °ñ¼ö¿°
    ¹Ì¸¸¼ºÀÇ Ä¡ÃßÁúȯ¿¡ ÀÇÇÑ °¨¿°¿¡¼­ ºñ·ÔµÈ´Ù. ³·Àº Á¤µµÀÇ °¨¿°¿¡ ´ëÇÑ °ñÀÇ Áõ½Ä¼º ¹ÝÀÀÀÌ´Ù. ³ë³âÃþÀÇ ¹«Ä¡¾Ç ºÎÀ§¿¡ ÁÖ·Î »ý±ä´Ù. Ưº°ÇÑ ¼Ò°ßÀº ¾ø´Ù. °ñÀÇ ¹Ì¸¸¼º °æÈ­°¡ ½ÉÇÏ°í ¾çÃø¼ºÀÌ´Ù. °æ°è´Â ºÒ¸í·áÇÏ´Ù. Á¶Á÷º´¸®ÇÐÀû ¼Ò°ßÀº Á¶¹ÐÇÏ°í ºÒ±ÔÄ¢ÇÑ °ñ¼ö, ¼¶À¯¼º °ñ¼ö°­ÀÌ´Ù.
  • sclerosing
    °æÈ­ÀÇ, °æÈ­¼ºÀÇ
  • sclerosing gastritis
    °æÈ­¼º À§¿°
  • sclerosing keratitis
    °æÈ­¼º °¢¸·¿°
    ºñÈļº °ø¸·¿°À» ¼ö¹ÝÇÏ´Â °¢¸·¿°.
  • sclerosing myelitis
    °æÈ­¼º ô¼ö¿°
  • sclerosing osteogenic sarcoma
    °æÈ­¼º °ñ À°Á¾
  • sclerosing seratitis
    °æÈ­¼º °¢¸·¿°
  • abetting agent
    Á¶Àå¹°
    ÁÖ ¾à¹°ÀÇ ¾àÈ¿¸¦ º¸Á¶Çϰí, ÁÖ ¾à¹°ÀÇ À¯ÇØÇÑ ÀÛ¿ëÀ» ¸·°Å³ª ¿ÏÈ­ÇÏ´Â ¸ñÀûÀ¸·Î »ç¿ëÇÏ´Â ¾à¹°.
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸° Â÷´ÜÁ¦
    ¾Æµå·¹³¯¸°¼º ¼ö¿ëü¿¡ ÀÛ¿ëÇÏ¿© ½Å°æ Àü´Þü¿Í ¼ö¿ëü°¡ °áÇÕÇÏÁö ¸øÇÏ°Ô ÇÔÀ¸·Î½á ±³°¨½Å°æ ÈïºÐ È¿°ú¸¦ ºÀ¼âÇÏ´Â ¾à¹°.
  • agent
    ¾à¹°, ¾à¹°Á¦, ÀÛ¿ë¹°Áú, º´ÀÎ
    ¹°¸®Àû, È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • anabolic agent
    µ¿È­ ¾à¹°
  • analgesic agent
    ÁøÅëÁ¦
    ½Å°æÀ» ¸¶ºñ½ÃÄÑ ¾ÆÇÄÀ» ÁøÁ¤½ÃŰ´Â ¾àÁ¦. ¸ôÇÉ, ¾ÈƼÇǸ° µîÀÌ ÀÖ´Ù.
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶Ãë, ¸¶ÃëÁ¦
    µ¿ÀǾî=anesthetic drug.
  • anorexigenic agent
    ½Ä¿å ¾ïÁ¦Á¦
  • anti-inflammatory agent
    Ç׿°Áõ ¾à, ¼Ò¿°Á¦, Ç׿°ÁõÁ¦
    ¿°Áõ¿¡ ¹Ý´ë·Î ÀÛ¿ëÇϰųª ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
sclerosing agent A compound which acts by irritation of the veinous intimal epithelium; used in the treatment of varicose veins.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
radial sclerosing lesion A variant of sclerosing adenosis of the breast with central scar formation and radiating hyperplastic ducts.
Synonym: radial scar.
(05 Mar 2000)
cholangitis, sclerosing Chronic, nonbacterial inflammatory narrowing of the bile ducts. About 50% of the cases are associated with ulcerative colitis. Treatment is to relieve the obstruction by balloon dilatation or surgery.
(12 Dec 1998)
chronic diffuse sclerosing osteomyelitis A proliferative reaction of bone to a low-grade infection of the jaws; most often seen in middle-aged or older black women as extensive, often bilateral radio-opacities of the mandible and maxilla.
(05 Mar 2000)
chronic focal sclerosing osteomyelitis A reaction of bone to a mild bacterial infection, often the result of a carious tooth, in persons with a high degree of tissue resistance; results in a localised radio-opacity.
Synonym: focal condensing osteitis.
(05 Mar 2000)
primary sclerosing cholangitis <radiology> Idiopathic, associated with IBD (50%), usually UC, M more than F, peak age 20-30 years of age, chronic inflammation and fibrosis of all bile ducts, stricture, obstruction, abscess (string of beads), intramural pseudo-diverticula, cholangiocarcinoma (10%!!), dilatation proximal to stricture may signal carcinoma Differential diagnosis: cholangiocarcinomarcinoma (diffuse form), primary biliary cirrhosis (PBC), AIDS-related cholangitis (? due to CMV)
(12 Dec 1998)
sclerosing adenosis A nodular, benign breast lesion occurring most frequently in relatively young women and consisting of hyperplastic distorted lobules of acinar tissue with increased collagenous stroma; the changes may be difficult to distinguish microscopically from carcinoma. Also, a benign nodular microscopic lesion of the prostate consisting of acimar tissue with increased stroma; the basal cell layer shows characteristic smooth muscle metaplasia.
Synonym: adenofibrosis, fibrosing adenomatosis, fibrosing adenosis.
(05 Mar 2000)
sclerosing haemangioma <tumour> A benign lung or bronchial lesion, often subpleural, sometimes multiple, which forms hyalinised connective tissue.
Synonym: fibrous histiocytoma.
(05 Mar 2000)
sclerosing inflammation Inflammation leading to extensive formation of fibrous and scar tissue.
(05 Mar 2000)
sclerosing keratitis Inflammation of the cornea complicating scleritis; characterised by opacification of the corneal stroma.
(05 Mar 2000)
sclerosing leukoencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
sclerosing mastoiditis A chronic mastoiditis in which the trabeculae are greatly thickened, almost or entirely obliterating the cells.
(05 Mar 2000)
sclerosing of varicose veins A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver.
(27 Sep 1997)
sclerosing osteitis Fusiform thickening or increased density of bones, of unknown cause; it has been considered a form of chronic nonsuppurative osteomyelitis.
Synonym: condensing osteitis, Garre's disease.
Osteitis tuberculosa multiplex cystica, an osteitis of tuberculous origin, marked by numerous small cavities in the osseous substance.
Synonym: Jungling's disease.
(05 Mar 2000)
sclerosing solutions Chemical agents injected into veins to cause localised thrombosis and eventual fibrosis and obliteration of the vessels. They are used in the treatment of varicose veins, haemorrhoids, gastric and oesophageal varices, and peptic ulcer haemorrhage.
(12 Dec 1998)
sclerosing therapy A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver.
(27 Sep 1997)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
sclerosing agent A solution that irritates the tissue and cause it to sclerose (or scar and harden).
Ãâó: www.hemorrhoidsinplainenglish.com/hemorrhoid/gloss...
sclerosing agent Used when cysts are marsupalized. That is, the cyst is opened along the long side and laid out flat. An agent such as an antibiotic is injected inside the open cyst. This is much like picturing the cyst as an egg; and taking the egg, slicing it along the long way; then tossing the inside bit of the egg so you are left with a hollow shell cavity. The agent prevents the cyst from re-filling with fluid by stripping out the epithelial layer of the cyst. ...
Ãâó: www.pkdiet.com/glossary.htm
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agent
    ´ë¸®ÀÎ
  • Eaton agent
    (ÀÇ)ÀÌÆ° ÀÎÀÚ
  • Indian agent
    (¹Ì ij³ª´Ù)Àεð¾ð °ü¸®°ü
  • ad agent
    ±¤°í ´ëÇà¾÷ÀÚ
  • agent
    ´ë¸®ÀÎ;ÁÖ¼±ÀÎ;ÇàÀ§ÀÚ;ÀÛÀÎ
  • book agent
    ¼­Àû¿ÜÆÇ¿ø
  • business agent
    ¾÷¹«´ë¸®
  • commission agent
    °Å°£²Û;Á߸ÅÀÎ;»ç¼³ ¸¶±ÇÀå¼ö
  • consular agent
    ¿µ»ç ´ë¸®
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • county agent
    (¿¬¹æ.ÁÖÁ¤ºÎ°¡ ÆÄ°ßÇÑ)³ó»ç °í¹®
  • double agent
    ÀÌÁß °£Ã¸
  • estate agent
    ºÎµ¿»ê°ü¸®ÀÎ;Áß°³¾÷ÀÚ
  • fiscal agent
    À繫 ´ë¸® ±â°ü;À繫 ´ë¸®ÀÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á